About this trial
To Check Dermatological Safety of Test Products by 24 Hours Patch Testing
Eligibility criteria
Qualifiers
Subject scoring greater than 30 for Section 2 - Sensitive v/s Resistant skin in modified Dr Baumann's* skin type questionnaire.
Subject with sensitive skin as confirmed by Lactic Acid Stinging Test.
Disqualifiers
Subject having skin irritation, blemishes, excessive hair, moles, pigmentation, pimples, marks (e.g. tattoos (within the previous 3 months), scars, sunburn), open wounds, cuts, abrasions, irritation symptoms or any dermatological condition on the test site(s) i.e. back that can interfere with the reading.
Medication which may affect skin response and/or past medical history. 3) Subject having history of diabetes 4) Subject have history of mastectomy for cancer involving removal of lymph nodes within the past year, or treatment of any type of cancer within the last 6 months.
Trial design
Treatments tested in this trial
- 1)0.1% Pinorox® Cream 2)1% Pinorox® Cream 3)Base cream 4)Positive control 5)Negative control
Treatment groups
Locations
Sponsors and collaborators
NovoBliss Research Pvt Ltd
Lead sponsor
Ambe Phytoextracts Pvt. Ltd
Collaborator